Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Genetic marker analysis in head and neck cancer]

Magyar onkologia - 1 Jan 2001

Csuka O, Olasz J, Juhász A, Hargitai A, Remenár E, Kásler M

Abstract excerpt

Prognostication of head and neck cancer (HNCC) involves molecular identification of residual tumor cells, prediction of recurrence, distant metastases or secondary tumors and prediction of the sensitvity to therapy. Biomarkers of HNCC are mutations of p53, p16 and amplification of Cyclin D and E2F4. One hundred and fifty-two HNCC cases have been evaluated for p53, hMLH1, Cyclin D and p16 gene alterations using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cyclin-Dependent Kinase Inhibitor p16
Share to DNA Mismatch Repair

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p16

Share to Head and Neck Neoplasms

Share to MutL Protein Homolog 1

Share to MutS Homolog 2 Protein

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 12050711

Genes

E2F4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

[Genetic marker analysis in head and neck cancer]PMID 12050711Read ↗

[Cellular and neoplastic otorhinolaryngologic changes, molecular markers and therapeutic potential].Semantic proximity Read ↗

[Epigenetic aspects in carcinomas of the head and neck].Semantic proximity Read ↗

Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.Semantic proximity Read ↗

[Molecular biology and immunohistochemical prognostic markers in head and neck squamous epithelial carcinomas].Semantic proximity Read ↗

P53 genotyping - an effective concept for molecular testing of head and neck cancer?Semantic proximity Read ↗

p16 mutation frequency and clinical correlation in head and neck cancer.Semantic proximity Read ↗

p53 tumor suppressor protein and H-RAS oncogene in maxillofacial tumors: immunohistochemical and genetic investigation, induction chemotherapy response and prognosis evaluation.Semantic proximity Read ↗

[Examinations on the importance of the inactivation of the tumor suppressor gene p16, reactivation of the telomerase and mutation of p53 in the pathogenesis of head and neck tumors].Semantic proximity Read ↗

[p53 mutations and chemoresistance in oromaxillofacial squamous-cell carcinomas. The results of a molecular genetics study of p53 in metastatic oromaxillofacial tumors and an evaluation of the response to neoadjuvant chemotherapeutic treatment].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.